News

Regeneron declines to make higher bid for 23andMe after Wojcicki's $305 million offer
Regeneron Pharmaceuticals has declined to submit a new bid for genetic testing company 23andMe exceeding its original winning ...
BioSpace10h
Regeneron Backs Off 23andMe, Losing Bid to Former CEO
Regeneron did not bid higher on the genetic testing company because of “its assessment of 23andMe’s remaining value,” ...
Regeneron CEO on 23andMe bid: Trying to balance individual privacy with biotech & genetics research
Regeneron founder, chairman and CEO Dr. Leonard Schleifer joins 'Squawk Box' to discuss the company's bid for 23andMe, ...
Why is Anne Wojcicki regaining control of 23andMe and what it means for genomics firm
Anne Wojcicki is taking back reins of 23andMe after outbidding Regeneron. The entrepreneur's proposal offers better ...
Congress Demands Answers on Data Privacy Ahead of 23andMe Sale
House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...
Almost 2 million 23andMe users have asked the company to delete their data in the last 2 months
Me's Interim CEO Joe Selsavage said 1.9 million customers have asked the company delete their data since March.
Lohud.com, Westchester County on MSN4d
NY sues 23andMe to block sale of your genetic data to the highest bidder. What to know
New York and 27 other states sued bankrupt genetic testing company 23andMe to block the sale of 15 million customers' ...
States take legal action as 23andMe attempts to sell customer genetic information amid bankruptcy
Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S. Bankruptcy Court for ...